Multivalent protein nanocages improve the safety profile of cluster of differentiation 47 checkpoint blockade.
Protein-based nanocages are emerging as promising platforms for next-generation medicine because of their programmable architecture, biocompatibility, and capacity for functional integration. In the field of immunotherapy, these properties offer a structural basis for overcoming key limitations of conventional antibody...